Why Supplement NDA and Intellectual Property Protection Matters for Brand Owners

At SREKE, we understand that your formulation is your most valuable asset. When you partner with a contract manufacturer, you are entrusting them with proprietary blends, unique delivery systems, and trade secrets that define your brand. A well-structured Non-Disclosure Agreement (NDA) and robust intellectual property (IP) protection framework are not optional — they are essential to your business success.

In the dietary supplement industry, formula theft and unauthorized replication remain real risks. According to industry reports from the Natural Products Association (NPA), brand owners lose an estimated $1.2 billion annually to counterfeit and knock-off products. Protecting your innovation from the moment you share it with a manufacturing partner is critical.

At SREKE, we take IP protection seriously. Our facility in Guangzhou operates under strict confidentiality protocols, and we require all clients to execute mutual NDAs before any formulation discussions begin. This ensures that your ideas, formulas, and business strategies remain protected at every stage of development.

Key Manufacturing Considerations at SREKE

Confidentiality Agreements and NDA Framework

Before we begin any project, we require both parties to sign a comprehensive NDA. This agreement covers:

• Proprietary formulations and ingredient ratios
• Packaging designs and label artwork
• Business strategies and pricing models
• Supplier and sourcing information
• Marketing plans and launch timelines

Our legal team reviews each NDA to ensure it meets the standards required by both Chinese and international jurisdictions, including compliance with the U.S. FDA's current Good Manufacturing Practice (cGMP) regulations under 21 CFR Part 111 and the EU's EFSA guidelines.

Formula Registration and Patent Support

While SREKE does not file patents on behalf of our clients, we provide the documentation and technical support necessary for you to protect your intellectual property. This includes:

• Detailed formulation records with batch-specific ingredient certifications
• Manufacturing process documentation suitable for patent applications
• COA (Certificate of Analysis) templates that verify unique ingredient combinations
• Support letters confirming your exclusive use of proprietary processes at our facility

For brands seeking patent protection, we recommend consulting with a registered patent attorney in your jurisdiction. In the United States, the USPTO accepts supplement formula patents under utility patent classifications, while design patents may apply to unique capsule or packaging configurations.

Facility Security and Data Protection

Our Guangzhou manufacturing facility implements multiple layers of security to protect client formulations:

• Restricted access to R&D and formulation rooms
• Encrypted digital storage for all client data
• Employee non-disclosure agreements with non-compete clauses
• ISO 22000-certified food safety management system
• HACCP-compliant hazard analysis and critical control points

Every employee at SREKE signs a confidentiality agreement as a condition of employment. We conduct regular audits to ensure compliance with our data protection policies.

MOQ and Minimum Order Quantity Considerations

At SREKE, our MOQ varies by product type:

• Softgels: 5,000–10,000 units per SKU
• Tablets: 10,000–30,000 units per SKU
• Capsules: 5,000–15,000 units per SKU
• Powders: 1,000–5,000 kg per formula
• Gummies: 3,000–10,000 units per SKU
• Liquids: 2,000–5,000 units per SKU

Lower MOQs are available for clients who sign long-term supply agreements, which we view as a commitment to mutual IP protection and brand growth.

How SREKE Helps You Get to Market Faster

Streamlined NDA and Onboarding Process

At SREKE, we have optimized our client onboarding process to minimize time to market while maintaining the highest standards of IP protection. Here is what you can expect:

• Day 1: Sign mutual NDA and submit your formulation or concept
• Week 1–2: Our R&D team conducts formula evaluation and ingredient sourcing
• Week 3–4: Prototype development and stability testing begins
• Week 5–8: Sample approval, packaging design, and regulatory review
• Week 9–12: Full-scale production and quality assurance testing

Our average lead time from NDA signing to first shipment is 8–12 weeks for standard formulations. For custom or patented formulas, we allocate dedicated production lines to ensure no cross-contamination of intellectual property.

Regulatory Compliance Support

Compliance is at the core of everything we do. SREKE holds the following certifications:

• FDA-registered facility (Registration Number: 3018763026)
• ISO 22000:2018 certified
• HACCP certified
• Kosher and Halal certified
• GMP compliant per 21 CFR Part 111

Our compliance team assists with label review, ingredient substantiation, and regulatory documentation to ensure your product meets FDA, EFSA, and other relevant market requirements before it reaches consumers.

Dedicated Account Management

Every SREKE client is assigned a dedicated account manager who serves as your single point of contact throughout the entire process. This ensures consistent communication, faster decision-making, and stronger protection of your confidential information.

Industry Trends and Market Opportunities

Growth in Proprietary Blend Protection

The global dietary supplement market was valued at approximately $180 billion in 2024 and is projected to reach $250 billion by 2028, according to data from Grand View Research. As competition intensifies, brand owners are investing more heavily in IP protection strategies, including proprietary blends, patented delivery systems, and exclusive ingredient sourcing agreements.

Rise of Clinical-Grade Contract Manufacturing

Consumers and retailers are increasingly demanding clinically studied ingredients and third-party tested products. SREKE responds by partnering with contract research organizations (CROs) and offering in-house stability testing that supports clinical substantiation for your marketing claims.

Sustainability and Clean Label Trends

The clean label movement continues to drive innovation in supplement manufacturing. At SREKE, we support brands looking to formulate with recognizable, non-GMO, and sustainably sourced ingredients while maintaining full IP protection through our NDA framework.

Emerging Markets and Export Opportunities

Chinese supplement manufacturers are expanding their reach into North American, European, and Middle Eastern markets. SREKE holds export certifications that facilitate compliance with FDA, EU, and GCC regulatory requirements, helping our clients launch products in multiple jurisdictions without compromising formula confidentiality.

Frequently Asked Questions

What is an NDA in supplement manufacturing?

A Non-Disclosure Agreement (NDA) is a legally binding contract between a supplement brand and its contract manufacturer that protects confidential information, including formulations, processes, and business strategies. At SREKE, we require a mutual NDA before any formula discussions begin.

Does SREKE protect my formula from being shared with other clients?

Absolutely. We maintain strict confidentiality protocols, including isolated formulation rooms, encrypted data storage, and employee NDAs. Your formula is never shared with other clients, and we do not produce identical products for competing brands.

Can I patent my supplement formula?

Yes. While SREKE does not file patents on your behalf, we provide the technical documentation and manufacturing records you need to support a patent application. We recommend working with a qualified patent attorney to determine the best protection strategy for your formula.

What certifications does SREKE hold?

SREKE is an FDA-registered, GMP-certified facility holding ISO 22000 and HACCP certifications. We also offer Kosher and Halal certified manufacturing options for clients who require these designations.

What are your MOQ requirements?

Our MOQs range from 5,000 units for softgels and capsules to 10,000–30,000 units for tablets. Powder and liquid MOQs start at 1,000 kg and 2,000 units respectively. Lower MOQs are available for long-term partnership agreements.

How long does it take to produce a supplement order?

Typical lead times range from 8 to 12 weeks from NDA signing to shipment, depending on formula complexity, packaging requirements, and regulatory considerations. Rush production is available for urgent launches.

Can SREKE help with US FDA compliance?

Yes. Our compliance team is experienced in FDA 21 CFR Part 111 requirements, including facility registration, supplement listing, and label compliance. We also support EFSA compliance for European market launches.

Do you offer private label or custom formulation services?

We offer both. Private label options allow you to launch quickly with our existing formulas, while custom ODM services let us develop a unique formula tailored to your brand. Both options are protected under our NDA framework.

Ready to launch your supplement brand? SREKE provides GMP-certified OEM/ODM manufacturing for softgels, capsules, tablets, powders, gummies, and liquids. Contact us for a free quote or email [email protected] — we respond within 24 hours.